The tenure of the NCDs will be up to 36 months, with interest payable monthly. The debentures will be listed on BSE Limited and secured by a subservient charge through hypothecation and mortgage. On Friday (July 11), shares of Neogen Chemicals Ltd ended at ₹1,583.60, down by ₹10.40, or 0.65%, on the BSE.
Speciality chemicals maker, Neogen Chemicals Limited, on Saturday (July 12), announced that its board of directors has approved raising up to ₹200 crore through the issuance of fully paid, secured, listed, rated, redeemable, rupee-denominated, non-cumulative, non-convertible debentures (NCDs) on a private placement basis.
The tenure of the NCDs will be up to 36 months, with interest payable monthly. The debentures will be listed on BSE Limited and secured by a subservient charge through hypothecation and mortgage.
Separately, the company disclosed that it received a fine from BSE Limited amounting to ₹3,61,080 (including GST) for non-compliance with Regulation 17(1A) of the SEBI Listing Regulations.
Also Read: Neogen Chemicals drops 4% after major fire incident at Gujarat plant
The violation pertained to the reappointment of a Non-Executive Independent Director over the age of 75 without explicitly referencing the specific regulation in the special resolution and explanatory statement.
The company is in the business of manufacturing speciality Chemicals. Neogen Chemicals has four manufacturing facilities in Maharashtra, Gujarat and Hyderabad.
On Friday (July 11), shares of Neogen Chemicals Ltd ended at ₹1,583.60, down by ₹10.40, or 0.65%, on the BSE.
Also Read: Neogen Chemicals MD outlines FY26 revenue targets, including for battery segment
First Published:
Jul 12, 2025 5:19 PM
IST
